1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Qiagen N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
Delayed Nyse  -  05/27 04:00:02 pm EDT
47.39 USD   +3.86%
05/26QIAGEN NV : Gets a Buy rating from Deutsche Bank
MD
05/24TRANSCRIPT : QIAGEN N.V. Presents at UBS Global Healthcare Conference, May-24-2022 10:45 AM
CI
05/24QIAGEN NV : Berenberg reiterates its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products

01/18/2022 | 04:05pm EDT

QIAGEN N.V. announced its new QIAwave product line by launching three nucleic acid extraction kits that use fewer components and produce less waste than existing ones. They are the first of their type to use both recycled plastics and space-saving chemical concentrates. The QIAwave RNA Mini Kit, QIAwave DNA Blood & Tissue Kit and QIAwave Plasmid Miniprep Kit use up to 63% less plastic and up to 42% less cardboard than QIAGEN’s most popular kits for extracting DNA, RNA and plasmid DNA from samples. That makes them a more sustainable alternative to existing products – a major step in reducing the environmental impact of QIAGEN’s overall portfolio. The new QIAwave products feature fewer components, waste tubes made from 100% recycled plastic, and suitable buffer concentrates in smaller bottles, rather than ready-to-go mixes. More compact kits and new ways of packing them reduce the amount of cardboard needed to box them up. Instructions for re-using some components are available online. QIAGEN aims to reduce plastic transportation packaging waste by a further 9% in 2022, having cut it by 9.6% in 2021. The company has striven to reduce its plastic footprint since the formation of its Plastic Footprint Task Force in 2018 – for example, by replacing expanded-polystyrene boxes for cooled shipments with recyclable alternatives and other forms of plastic packaging with more eco-friendly alternatives.


© S&P Capital IQ 2022
All news about QIAGEN N.V.
05/26QIAGEN NV : Gets a Buy rating from Deutsche Bank
MD
05/24TRANSCRIPT : QIAGEN N.V. Presents at UBS Global Healthcare Conference, May-24-2022 10:45 A..
CI
05/24QIAGEN NV : Berenberg reiterates its Buy rating
MD
05/19QIAGEN's Eco-Friendlier Products Earn Prestigious ACT Label
BU
05/16QIAGEN NV : Berenberg keeps its Buy rating
MD
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-D..
BU
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-D..
CI
05/11SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close
MT
05/11SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance
MT
05/11Qiagen to Acquire 96% Stake In BLIRT for Undisclosed Sum
MT
More news
Analyst Recommendations on QIAGEN N.V.
More recommendations
Financials (USD)
Sales 2022 2 093 M - -
Net income 2022 387 M - -
Net Debt 2022 497 M - -
P/E ratio 2022 27,7x
Yield 2022 -
Capitalization 10 779 M 10 779 M -
EV / Sales 2022 5,39x
EV / Sales 2023 5,05x
Nbr of Employees 6 000
Free-Float 98,2%
Chart QIAGEN N.V.
Duration : Period :
Qiagen N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 47,39 $
Average target price 56,32 $
Spread / Average Target 18,8%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Vice President-Finance
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Lezette Young Manager-Compliance & Legal
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-14.74%10 779
MODERNA, INC.-41.86%58 733
LONZA GROUP AG-24.79%44 437
IQVIA HOLDINGS INC.-21.85%41 736
SEAGEN INC.-8.54%26 026
ICON PUBLIC LIMITED COMPANY-26.61%18 478